MISSISSAUGA, ON, May 4, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the first quarter of 2023 on Thursday, May 11, 2023. The Company will also host a conference call on Friday, May 12, 2023 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: Friday, May 12, 2023
TIME: 8:30 a.m. EDT
DIAL-IN NUMBER: (416) 764-8650 or (888) 664-6383
CONFERENCE ID: 40452017
REPLAY DIAL-IN: (888) 390-0541 (playback 452017#)
Expires May 19, 2022
WEBCAST: https://app.webinar.net/wOPDyeLaKb0
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2023/04/c9102.html